Evidence map›Paper›PMID 40775053›Full record

ArticleNature medicine2025

Geographical shifting of cholera burden in Africa and its implications for disease control.

Javier Perez-Saez, Qulu Zheng, Joshua Kaminsky, Kaiyue Zou, Maya N Demby, Christina Alam, Daniel Landau, Rachel DePencier, Jose Paulo M Langa, Roma Chilengi and 16 more

Abstract read
In one paragraph

Article in Nature medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. A case for using spatial evidence in waterborne disease control.Bulletin of the World Health Organization · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Changes in cholera burden across Africa.Nature reviews. Gastroenterology & hepatology · 2025
    Article
  6. Care seeking for diarrheal illness: a systematic review and meta-analysis.medRxiv : the preprint server for health sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Javier Perez-Saez *Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID http://orcid.org/0000-0003-3909-2048
Qulu Zheng *Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Joshua KaminskyDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Kaiyue ZouDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-2568-8193
Maya N DembyDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-5315-325X
Christina AlamDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Daniel LandauMiddle Distance, Portland, OR, USA.
Rachel DePencierDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Jose Paulo M LangaInstituto Nacional de Saúde, Maputo, Mozambique.
Roma ChilengiZambia National Public Health Institute, Lusaka, Zambia.ORCID http://orcid.org/0000-0003-0221-9527
Placide Welo OkitayembaProgramme National d'Elimination de Choléra et lutte contre les autres Maladies Diarrhéiques, Kinshasa, Democratic Republic of the Congo.
Godfrey BwireDivision of Public Health Emergency Preparedness And Response, Ministry of Health, Kampala, Uganda.ORCID http://orcid.org/0000-0002-8376-2857
Linda EssoUniversity of Yaoundé I, Yaoundé, Cameroon.
Armelle Viviane NgombaMinistry of Public Health, Yaoundé, Cameroon.
Nicole Fouda MbargaWorld Health Organization Cameroon, Yaoundé, Cameroon.ORCID http://orcid.org/0000-0002-0508-8027
Emmanuel Wandera OkungaDisease Surveillance and Response, Ministry of Health, Nairobi, Kenya.
Sebastian YennanNigeria Centre for Disease Control and Prevention, Abuja, Nigeria.
Fred KapayaWorld Health Organization Regional Office for Africa, Emergency Preparedness and Response Program, Nairobi, Kenya.
Stephen Ogirima OhizeThe International Federation of Red Cross and Red Crescent Societies, Abuja, Nigeria.ORCID http://orcid.org/0000-0001-9206-1596
Adive Joseph SerikiThe International Federation of Red Cross and Red Crescent Societies, Geneva, Switzerland.
Sonia T HegdeDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-6426-0096
Mustafa SikderIndependent researcher, Rockville, MD, USA.ORCID http://orcid.org/0000-0002-6977-7913
Justin LesslerDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Abhirup DattaDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Andrew S AzmanDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-8662-9077
Elizabeth C LeeDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. elizabeth.c.lee@jhu.edu.ORCID http://orcid.org/0000-0002-4156-9637

Funding

Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation) INV-044865World Health Organization 001
6 · The paper itself

Abstract

Cholera outbreaks cause substantial morbidity and mortality in Africa, yet changes in the geographic distribution of cholera burden over time remain uncharacterized. We used surveillance data and spatial statistical models to estimate the mean annual incidence of reported suspected cholera for 2011-2015 and 2016-2020 on a 20-km grid across Africa. Across 43 countries, mean annual incidence rates remained at 11 cases per 100,000 population, with 125,701 cases estimated annually (95% credible interval (CrI): 124,737-126,717) from 2016 to 2020. Cholera incidence shifted from western to eastern Africa. There were 296 million people (95% CrI: 282-312 million) in high-incidence second-level administrative (ADM2) units (≥10 cases per 100,000 per year) in 2020, 135 million of whom experienced low incidence (<1 per 100,000) in 2011-2015. ADM2 units with high incidence in central and eastern Africa from 2011 to 2020 were more likely to report cholera in 2022-2023. In hypothetical scenarios of preventive disease control planning, targeting the 100 million highest-burden populations had potential to reach up to 63% of 2016-2020 mean annual cases but only 37% when targeting by past incidence. This retrospective analysis highlights spatiotemporal instability in cholera burden and can be used as a benchmark for tracking future progress in disease control.

Indexed as

CholeraAfricaDisease OutbreaksHumansIncidence

Identifiers

PMID40775053
PMCPMC12532610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.